OGN

ORGANON & CO

• Benzinga·5d ago

  Organon To Present Phase 3 Data Of VTAMA Cream In Atopic Dermatitis At 2026 Society For Pediatric Dermatology Annual Meeting

• Seeking Alpha·06/25 17:59

  Record-setting healthcare M&A activity to extend through H2: PwC

• Seeking Alpha·06/23 10:28

  Organon and Henlius launch Prolia and Xgeva biosimilars in Canada

• TipRanks·06/22 11:35

  Organon completes agreement to license MIUDELLA hormone-free IUD

• TipRanks·06/18 10:13

  Organon and Samsung Bioepis expand commercialization agreement for Pyzchiva

• Benzinga·06/18 10:08

  Organon And Samsung Bioepis Expand Their Development And Commercialization Agreement To Provide OGN With Commercialization Rights In Canada To PYZCHIVA, Samsung Bioepis's Biosimilar Referencing STELARA

• TipRanks·06/17 10:47

  Organon Sets July Vote on $14‑per‑Share Sun Pharma Takeover

• Simply Wall St·06/13 16:24

  Organon (OGN) Stock Valuation After FDA Expands TOFIDENCE Approval In US Biosimilars Market

• Simply Wall St·06/12 12:38

  How FDA’s Expanded TOFIDENCE Approval in CRS and COVID-19 Could Shape Organon’s (OGN) Biosimilar Strategy

• TipRanks·06/11 21:43

  Organon Shareholders Approve Board, Pay and Incentive Plan

• TipRanks·06/10 11:34

  Organon announces U.S. FDA approval pf sBLA for Tofidence injection

• Benzinga·06/10 11:33

  Organon's Supplemental Biologics License Application Gets FDA Approval For TOFIDENCE To Treat Chimeric Antigen Receptor T Cell-Induced Severe Or Life-Threatening Cytokine Release Syndrome

• Seeking Alpha·05/18 11:39

  Deep value mid-caps: 10 names trading at single-digit forward P/Es

• TipRanks·05/15 11:46

  Organon to present new research at ISPOR 2026

• Seeking Alpha·05/09 15:03

  Insider trades: Intel, Bank of America, and Pinterest among notable names